# An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

> **NCT06999798** · PHASE1 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 20 (estimated)

## Conditions studied

- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Locally Advanced Breast Carcinoma

## Interventions

- **PROCEDURE:** Diagnostic Mammography
- **PROCEDURE:** Resection
- **PROCEDURE:** Ultrasound Imaging
- **DEVICE:** Twinkling Marker Placement

## Key facts

- **NCT ID:** NCT06999798
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-29
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06999798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06999798, "An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06999798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*